Global Pharmaceutical CXO Market 2021 by Company, Regions, Type and Application, Forecast to 2026
Page: 112
Published Date: 12 Aug 2021
Category: Service & Software
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Pharmaceutical CXO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pharmaceutical CXO size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Pharmaceutical CXO market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pharmaceutical CXO market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CRO
CMO
CDMO
Market segment by Application, can be divided into
Pharmaceutical Companies
Biotechnology Companies
Market segment by players, this report covers
WuXi AppTec
Tigermed
Charles River Laboratories
Pharmaron Inc
Labcorp Drug Development
Boehringer Ingelheim
GenScript
MabPlex International
Shanghai ChemPartner
Wuxi Biologics
Pharmablock
Jiuzhou Pharma
Asym Chemical
IQVIA
Syneos Health
Parexel
AGC Biologics
FUJIFILM Diosynth Biotechnologies
Patheon
Catalent
Lonza Group AG
Avid Bioservices
AbbVie
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pharmaceutical CXO product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pharmaceutical CXO, with revenue, gross margin and global market share of Pharmaceutical CXO from 2019 to 2021.
Chapter 3, the Pharmaceutical CXO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Pharmaceutical CXO market forecast, by regions, type and end user, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Pharmaceutical CXO research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical CXO
1.2 Classification of Pharmaceutical CXO by Type
1.2.1 Overview: Global Pharmaceutical CXO Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Pharmaceutical CXO Revenue Market Share by Type in 2020
1.2.3 CRO
1.2.4 CMO
1.2.5 CDMO
1.3 Global Pharmaceutical CXO Market by End User
1.3.1 Overview: Global Pharmaceutical CXO Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnology Companies
1.4 Global Pharmaceutical CXO Market Size & Forecast
1.5 Global Pharmaceutical CXO Market Size and Forecast by Region
1.5.1 Global Pharmaceutical CXO Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Pharmaceutical CXO Market Size by Region, (2016-2021)
1.5.3 North America Pharmaceutical CXO Market Size and Prospect (2016-2026)
1.5.4 Europe Pharmaceutical CXO Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Pharmaceutical CXO Market Size and Prospect (2016-2026)
1.5.6 South America Pharmaceutical CXO Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Pharmaceutical CXO Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmaceutical CXO Market Drivers
1.6.2 Pharmaceutical CXO Market Restraints
1.6.3 Pharmaceutical CXO Trends Analysis
2.1 WuXi AppTec
2.1.1 WuXi AppTec Details
2.1.2 WuXi AppTec Major Business
2.1.3 WuXi AppTec Pharmaceutical CXO Product and Solutions
2.1.4 WuXi AppTec Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 WuXi AppTec Recent Developments and Future Plans
2.2 Tigermed
2.2.1 Tigermed Details
2.2.2 Tigermed Major Business
2.2.3 Tigermed Pharmaceutical CXO Product and Solutions
2.2.4 Tigermed Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Tigermed Recent Developments and Future Plans
2.3 Charles River Laboratories
2.3.1 Charles River Laboratories Details
2.3.2 Charles River Laboratories Major Business
2.3.3 Charles River Laboratories Pharmaceutical CXO Product and Solutions
2.3.4 Charles River Laboratories Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Charles River Laboratories Recent Developments and Future Plans
2.4 Pharmaron Inc
2.4.1 Pharmaron Inc Details
2.4.2 Pharmaron Inc Major Business
2.4.3 Pharmaron Inc Pharmaceutical CXO Product and Solutions
2.4.4 Pharmaron Inc Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pharmaron Inc Recent Developments and Future Plans
2.5 Labcorp Drug Development
2.5.1 Labcorp Drug Development Details
2.5.2 Labcorp Drug Development Major Business
2.5.3 Labcorp Drug Development Pharmaceutical CXO Product and Solutions
2.5.4 Labcorp Drug Development Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Labcorp Drug Development Recent Developments and Future Plans
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Pharmaceutical CXO Product and Solutions
2.6.4 Boehringer Ingelheim Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Boehringer Ingelheim Recent Developments and Future Plans
2.7 GenScript
2.7.1 GenScript Details
2.7.2 GenScript Major Business
2.7.3 GenScript Pharmaceutical CXO Product and Solutions
2.7.4 GenScript Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 GenScript Recent Developments and Future Plans
2.8 MabPlex International
2.8.1 MabPlex International Details
2.8.2 MabPlex International Major Business
2.8.3 MabPlex International Pharmaceutical CXO Product and Solutions
2.8.4 MabPlex International Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 MabPlex International Recent Developments and Future Plans
2.9 Shanghai ChemPartner
2.9.1 Shanghai ChemPartner Details
2.9.2 Shanghai ChemPartner Major Business
2.9.3 Shanghai ChemPartner Pharmaceutical CXO Product and Solutions
2.9.4 Shanghai ChemPartner Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Shanghai ChemPartner Recent Developments and Future Plans
2.10 Wuxi Biologics
2.10.1 Wuxi Biologics Details
2.10.2 Wuxi Biologics Major Business
2.10.3 Wuxi Biologics Pharmaceutical CXO Product and Solutions
2.10.4 Wuxi Biologics Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Wuxi Biologics Recent Developments and Future Plans
2.11 Pharmablock
2.11.1 Pharmablock Details
2.11.2 Pharmablock Major Business
2.11.3 Pharmablock Pharmaceutical CXO Product and Solutions
2.11.4 Pharmablock Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Pharmablock Recent Developments and Future Plans
2.12 Jiuzhou Pharma
2.12.1 Jiuzhou Pharma Details
2.12.2 Jiuzhou Pharma Major Business
2.12.3 Jiuzhou Pharma Pharmaceutical CXO Product and Solutions
2.12.4 Jiuzhou Pharma Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Jiuzhou Pharma Recent Developments and Future Plans
2.13 Asym Chemical
2.13.1 Asym Chemical Details
2.13.2 Asym Chemical Major Business
2.13.3 Asym Chemical Pharmaceutical CXO Product and Solutions
2.13.4 Asym Chemical Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Asym Chemical Recent Developments and Future Plans
2.14 IQVIA
2.14.1 IQVIA Details
2.14.2 IQVIA Major Business
2.14.3 IQVIA Pharmaceutical CXO Product and Solutions
2.14.4 IQVIA Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 IQVIA Recent Developments and Future Plans
2.15 Syneos Health
2.15.1 Syneos Health Details
2.15.2 Syneos Health Major Business
2.15.3 Syneos Health Pharmaceutical CXO Product and Solutions
2.15.4 Syneos Health Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Syneos Health Recent Developments and Future Plans
2.16 Parexel
2.16.1 Parexel Details
2.16.2 Parexel Major Business
2.16.3 Parexel Pharmaceutical CXO Product and Solutions
2.16.4 Parexel Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Parexel Recent Developments and Future Plans
2.17 AGC Biologics
2.17.1 AGC Biologics Details
2.17.2 AGC Biologics Major Business
2.17.3 AGC Biologics Pharmaceutical CXO Product and Solutions
2.17.4 AGC Biologics Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 AGC Biologics Recent Developments and Future Plans
2.18 FUJIFILM Diosynth Biotechnologies
2.18.1 FUJIFILM Diosynth Biotechnologies Details
2.18.2 FUJIFILM Diosynth Biotechnologies Major Business
2.18.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Product and Solutions
2.18.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.19 Patheon
2.19.1 Patheon Details
2.19.2 Patheon Major Business
2.19.3 Patheon Pharmaceutical CXO Product and Solutions
2.19.4 Patheon Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Patheon Recent Developments and Future Plans
2.20 Catalent
2.20.1 Catalent Details
2.20.2 Catalent Major Business
2.20.3 Catalent Pharmaceutical CXO Product and Solutions
2.20.4 Catalent Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Catalent Recent Developments and Future Plans
2.21 Lonza Group AG
2.21.1 Lonza Group AG Details
2.21.2 Lonza Group AG Major Business
2.21.3 Lonza Group AG Pharmaceutical CXO Product and Solutions
2.21.4 Lonza Group AG Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Lonza Group AG Recent Developments and Future Plans
2.22 Avid Bioservices
2.22.1 Avid Bioservices Details
2.22.2 Avid Bioservices Major Business
2.22.3 Avid Bioservices Pharmaceutical CXO Product and Solutions
2.22.4 Avid Bioservices Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.22.5 Avid Bioservices Recent Developments and Future Plans
2.23 AbbVie
2.23.1 AbbVie Details
2.23.2 AbbVie Major Business
2.23.3 AbbVie Pharmaceutical CXO Product and Solutions
2.23.4 AbbVie Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2021)
2.23.5 AbbVie Recent Developments and Future Plans
3.1 Global Pharmaceutical CXO Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Pharmaceutical CXO Players Market Share
3.2.2 Top 10 Pharmaceutical CXO Players Market Share
3.2.3 Market Competition Trend
3.3 Pharmaceutical CXO Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4.1 Global Pharmaceutical CXO Revenue and Market Share by Type (2016-2021)
4.2 Global Pharmaceutical CXO Market Forecast by Type (2021-2026)
5.1 Global Pharmaceutical CXO Revenue Market Share by Application (2016-2021)
5.2 Pharmaceutical CXO Market Forecast by Application (2021-2026)
6.1 North America Pharmaceutical CXO Revenue by Type (2016-2026)
6.2 North America Pharmaceutical CXO Revenue by Application (2016-2026)
6.3 North America Pharmaceutical CXO Market Size by Country
6.3.1 North America Pharmaceutical CXO Revenue by Country (2016-2026)
6.3.2 United States Pharmaceutical CXO Market Size and Forecast (2016-2026)
6.3.3 Canada Pharmaceutical CXO Market Size and Forecast (2016-2026)
6.3.4 Mexico Pharmaceutical CXO Market Size and Forecast (2016-2026)
7.1 Europe Pharmaceutical CXO Revenue by Type (2016-2026)
7.2 Europe Pharmaceutical CXO Revenue by Application (2016-2026)
7.3 Europe Pharmaceutical CXO Market Size by Country
7.3.1 Europe Pharmaceutical CXO Revenue by Country (2016-2026)
7.3.2 Germany Pharmaceutical CXO Market Size and Forecast (2016-2026)
7.3.3 France Pharmaceutical CXO Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Pharmaceutical CXO Market Size and Forecast (2016-2026)
7.3.5 Russia Pharmaceutical CXO Market Size and Forecast (2016-2026)
7.3.6 Italy Pharmaceutical CXO Market Size and Forecast (2016-2026)
8.1 Asia-Pacific Pharmaceutical CXO Revenue by Type (2016-2026)
8.2 Asia-Pacific Pharmaceutical CXO Revenue by Application (2016-2026)
8.3 Asia-Pacific Pharmaceutical CXO Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical CXO Revenue by Region (2016-2026)
8.3.2 China Pharmaceutical CXO Market Size and Forecast (2016-2026)
8.3.3 Japan Pharmaceutical CXO Market Size and Forecast (2016-2026)
8.3.4 South Korea Pharmaceutical CXO Market Size and Forecast (2016-2026)
8.3.5 India Pharmaceutical CXO Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Pharmaceutical CXO Market Size and Forecast (2016-2026)
8.3.7 Australia Pharmaceutical CXO Market Size and Forecast (2016-2026)
9.1 South America Pharmaceutical CXO Revenue by Type (2016-2026)
9.2 South America Pharmaceutical CXO Revenue by Application (2016-2026)
9.3 South America Pharmaceutical CXO Market Size by Country
9.3.1 South America Pharmaceutical CXO Revenue by Country (2016-2026)
9.3.2 Brazil Pharmaceutical CXO Market Size and Forecast (2016-2026)
9.3.3 Argentina Pharmaceutical CXO Market Size and Forecast (2016-2026)
10.1 Middle East & Africa Pharmaceutical CXO Revenue by Type (2016-2026)
10.2 Middle East & Africa Pharmaceutical CXO Revenue by Application (2016-2026)
10.3 Middle East & Africa Pharmaceutical CXO Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical CXO Revenue by Country (2016-2026)
10.3.2 Turkey Pharmaceutical CXO Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Pharmaceutical CXO Market Size and Forecast (2016-2026)
10.3.4 UAE Pharmaceutical CXO Market Size and Forecast (2016-2026)
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Pharmaceutical CXO Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Pharmaceutical CXO Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Pharmaceutical CXO Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Pharmaceutical CXO Revenue (USD Million) by Region (2016-2021)
Table 5. Global Pharmaceutical CXO Revenue Market Share by Region (2021-2026)
Table 6. WuXi AppTec Corporate Information, Head Office, and Major Competitors
Table 7. WuXi AppTec Major Business
Table 8. WuXi AppTec Pharmaceutical CXO Product and Solutions
Table 9. WuXi AppTec Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Tigermed Corporate Information, Head Office, and Major Competitors
Table 11. Tigermed Major Business
Table 12. Tigermed Pharmaceutical CXO Product and Solutions
Table 13. Tigermed Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Charles River Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Charles River Laboratories Major Business
Table 16. Charles River Laboratories Pharmaceutical CXO Product and Solutions
Table 17. Charles River Laboratories Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pharmaron Inc Corporate Information, Head Office, and Major Competitors
Table 19. Pharmaron Inc Major Business
Table 20. Pharmaron Inc Pharmaceutical CXO Product and Solutions
Table 21. Pharmaron Inc Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Labcorp Drug Development Corporate Information, Head Office, and Major Competitors
Table 23. Labcorp Drug Development Major Business
Table 24. Labcorp Drug Development Pharmaceutical CXO Product and Solutions
Table 25. Labcorp Drug Development Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 27. Boehringer Ingelheim Major Business
Table 28. Boehringer Ingelheim Pharmaceutical CXO Product and Solutions
Table 29. Boehringer Ingelheim Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. GenScript Corporate Information, Head Office, and Major Competitors
Table 31. GenScript Major Business
Table 32. GenScript Pharmaceutical CXO Product and Solutions
Table 33. GenScript Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. MabPlex International Corporate Information, Head Office, and Major Competitors
Table 35. MabPlex International Major Business
Table 36. MabPlex International Pharmaceutical CXO Product and Solutions
Table 37. MabPlex International Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Shanghai ChemPartner Corporate Information, Head Office, and Major Competitors
Table 39. Shanghai ChemPartner Major Business
Table 40. Shanghai ChemPartner Pharmaceutical CXO Product and Solutions
Table 41. Shanghai ChemPartner Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Wuxi Biologics Corporate Information, Head Office, and Major Competitors
Table 43. Wuxi Biologics Major Business
Table 44. Wuxi Biologics Pharmaceutical CXO Product and Solutions
Table 45. Wuxi Biologics Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Pharmablock Corporate Information, Head Office, and Major Competitors
Table 47. Pharmablock Major Business
Table 48. Pharmablock Pharmaceutical CXO Product and Solutions
Table 49. Pharmablock Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Jiuzhou Pharma Corporate Information, Head Office, and Major Competitors
Table 51. Jiuzhou Pharma Major Business
Table 52. Jiuzhou Pharma Pharmaceutical CXO Product and Solutions
Table 53. Jiuzhou Pharma Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Asym Chemical Corporate Information, Head Office, and Major Competitors
Table 55. Asym Chemical Major Business
Table 56. Asym Chemical Pharmaceutical CXO Product and Solutions
Table 57. Asym Chemical Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. IQVIA Corporate Information, Head Office, and Major Competitors
Table 59. IQVIA Major Business
Table 60. IQVIA Pharmaceutical CXO Product and Solutions
Table 61. IQVIA Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Syneos Health Corporate Information, Head Office, and Major Competitors
Table 63. Syneos Health Major Business
Table 64. Syneos Health Pharmaceutical CXO Product and Solutions
Table 65. Syneos Health Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Parexel Corporate Information, Head Office, and Major Competitors
Table 67. Parexel Major Business
Table 68. Parexel Pharmaceutical CXO Product and Solutions
Table 69. Parexel Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. AGC Biologics Corporate Information, Head Office, and Major Competitors
Table 71. AGC Biologics Major Business
Table 72. AGC Biologics Pharmaceutical CXO Product and Solutions
Table 73. AGC Biologics Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. FUJIFILM Diosynth Biotechnologies Corporate Information, Head Office, and Major Competitors
Table 75. FUJIFILM Diosynth Biotechnologies Major Business
Table 76. FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Product and Solutions
Table 77. FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Patheon Corporate Information, Head Office, and Major Competitors
Table 79. Patheon Major Business
Table 80. Patheon Pharmaceutical CXO Product and Solutions
Table 81. Patheon Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Catalent Corporate Information, Head Office, and Major Competitors
Table 83. Catalent Major Business
Table 84. Catalent Pharmaceutical CXO Product and Solutions
Table 85. Catalent Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Lonza Group AG Corporate Information, Head Office, and Major Competitors
Table 87. Lonza Group AG Major Business
Table 88. Lonza Group AG Pharmaceutical CXO Product and Solutions
Table 89. Lonza Group AG Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Avid Bioservices Corporate Information, Head Office, and Major Competitors
Table 91. Avid Bioservices Major Business
Table 92. Avid Bioservices Pharmaceutical CXO Product and Solutions
Table 93. Avid Bioservices Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 94. AbbVie Corporate Information, Head Office, and Major Competitors
Table 95. AbbVie Major Business
Table 96. AbbVie Pharmaceutical CXO Product and Solutions
Table 97. AbbVie Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 98. Global Pharmaceutical CXO Revenue (USD Million) by Players (2019-2021)
Table 99. Global Pharmaceutical CXO Revenue Share by Players (2019-2021)
Table 100. Breakdown of Pharmaceutical CXO by Company Type (Tier 1, Tier 2 and Tier 3)
Table 101. Pharmaceutical CXO Players Head Office, Products and Services Provided
Table 102. Pharmaceutical CXO Mergers & Acquisitions in the Past Five Years
Table 103. Pharmaceutical CXO New Entrants and Expansion Plans
Table 104. Global Pharmaceutical CXO Revenue (USD Million) by Type (2016-2021)
Table 105. Global Pharmaceutical CXO Revenue Share by Type (2016-2021)
Table 106. Global Pharmaceutical CXO Revenue Forecast by Type (2021-2026)
Table 107. Global Pharmaceutical CXO Revenue by Application (2016-2021)
Table 108. Global Pharmaceutical CXO Revenue Forecast by Application (2021-2026)
Table 109. North America Pharmaceutical CXO Revenue by Type (2016-2021) & (USD Million)
Table 110. North America Pharmaceutical CXO Revenue by Type (2021-2026) & (USD Million)
Table 111. North America Pharmaceutical CXO Revenue by Application (2016-2021) & (USD Million)
Table 112. North America Pharmaceutical CXO Revenue by Application (2021-2026) & (USD Million)
Table 113. North America Pharmaceutical CXO Revenue by Country (2016-2021) & (USD Million)
Table 114. North America Pharmaceutical CXO Revenue by Country (2021-2026) & (USD Million)
Table 115. Europe Pharmaceutical CXO Revenue by Type (2016-2021) & (USD Million)
Table 116. Europe Pharmaceutical CXO Revenue by Type (2021-2026) & (USD Million)
Table 117. Europe Pharmaceutical CXO Revenue by Application (2016-2021) & (USD Million)
Table 118. Europe Pharmaceutical CXO Revenue by Application (2021-2026) & (USD Million)
Table 119. Europe Pharmaceutical CXO Revenue by Country (2016-2021) & (USD Million)
Table 120. Europe Pharmaceutical CXO Revenue by Country (2021-2026) & (USD Million)
Table 121. Asia-Pacific Pharmaceutical CXO Revenue by Type (2016-2021) & (USD Million)
Table 122. Asia-Pacific Pharmaceutical CXO Revenue by Type (2021-2026) & (USD Million)
Table 123. Asia-Pacific Pharmaceutical CXO Revenue by Application (2016-2021) & (USD Million)
Table 124. Asia-Pacific Pharmaceutical CXO Revenue by Application (2021-2026) & (USD Million)
Table 125. Asia-Pacific Pharmaceutical CXO Revenue by Region (2016-2021) & (USD Million)
Table 126. Asia-Pacific Pharmaceutical CXO Revenue by Region (2021-2026) & (USD Million)
Table 127. South America Pharmaceutical CXO Revenue by Type (2016-2021) & (USD Million)
Table 128. South America Pharmaceutical CXO Revenue by Type (2021-2026) & (USD Million)
Table 129. South America Pharmaceutical CXO Revenue by Application (2016-2021) & (USD Million)
Table 130. South America Pharmaceutical CXO Revenue by Application (2021-2026) & (USD Million)
Table 131. South America Pharmaceutical CXO Revenue by Country (2016-2021) & (USD Million)
Table 132. South America Pharmaceutical CXO Revenue by Country (2021-2026) & (USD Million)
Table 133. Middle East & Africa Pharmaceutical CXO Revenue by Type (2016-2021) & (USD Million)
Table 134. Middle East & Africa Pharmaceutical CXO Revenue by Type (2021-2026) & (USD Million)
Table 135. Middle East & Africa Pharmaceutical CXO Revenue by Application (2016-2021) & (USD Million)
Table 136. Middle East & Africa Pharmaceutical CXO Revenue by Application (2021-2026) & (USD Million)
Table 137. Middle East & Africa Pharmaceutical CXO Revenue by Country (2016-2021) & (USD Million)
Table 138. Middle East & Africa Pharmaceutical CXO Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Pharmaceutical CXO Picture
Figure 2. Global Pharmaceutical CXO Revenue Market Share by Type in 2020
Figure 3. CRO
Figure 4. CMO
Figure 5. CDMO
Figure 6. Pharmaceutical CXO Revenue Market Share by End User in 2020
Figure 7. Pharmaceutical Companies Picture
Figure 8. Biotechnology Companies Picture
Figure 9. Global Pharmaceutical CXO Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Pharmaceutical CXO Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Pharmaceutical CXO Revenue Market Share by Region (2016-2026)
Figure 12. Global Pharmaceutical CXO Revenue Market Share by Region in 2020
Figure 13. North America Pharmaceutical CXO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Pharmaceutical CXO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Pharmaceutical CXO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Pharmaceutical CXO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Pharmaceutical CXO Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Pharmaceutical CXO Market Drivers
Figure 19. Pharmaceutical CXO Market Restraints
Figure 20. Pharmaceutical CXO Market Trends
Figure 21. WuXi AppTec Recent Developments and Future Plans
Figure 22. Tigermed Recent Developments and Future Plans
Figure 23. Charles River Laboratories Recent Developments and Future Plans
Figure 24. Pharmaron Inc Recent Developments and Future Plans
Figure 25. Labcorp Drug Development Recent Developments and Future Plans
Figure 26. Boehringer Ingelheim Recent Developments and Future Plans
Figure 27. GenScript Recent Developments and Future Plans
Figure 28. MabPlex International Recent Developments and Future Plans
Figure 29. Shanghai ChemPartner Recent Developments and Future Plans
Figure 30. Wuxi Biologics Recent Developments and Future Plans
Figure 31. Pharmablock Recent Developments and Future Plans
Figure 32. Jiuzhou Pharma Recent Developments and Future Plans
Figure 33. Asym Chemical Recent Developments and Future Plans
Figure 34. IQVIA Recent Developments and Future Plans
Figure 35. Syneos Health Recent Developments and Future Plans
Figure 36. Parexel Recent Developments and Future Plans
Figure 37. AGC Biologics Recent Developments and Future Plans
Figure 38. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Figure 39. Patheon Recent Developments and Future Plans
Figure 40. Catalent Recent Developments and Future Plans
Figure 41. Lonza Group AG Recent Developments and Future Plans
Figure 42. Avid Bioservices Recent Developments and Future Plans
Figure 43. AbbVie Recent Developments and Future Plans
Figure 44. Global Pharmaceutical CXO Revenue Share by Players in 2020
Figure 45. Pharmaceutical CXO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 46. Global Top 3 Players Pharmaceutical CXO Revenue Market Share in 2020
Figure 47. Global Top 10 Players Pharmaceutical CXO Revenue Market Share in 2020
Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 49. Global Pharmaceutical CXO Revenue Share by Type in 2020
Figure 50. Global Pharmaceutical CXO Market Share Forecast by Type (2021-2026)
Figure 51. Global Pharmaceutical CXO Revenue Share by Application in 2020
Figure 52. Global Pharmaceutical CXO Market Share Forecast by Application (2021-2026)
Figure 53. North America Pharmaceutical CXO Sales Market Share by Type (2016-2026)
Figure 54. North America Pharmaceutical CXO Sales Market Share by Application (2016-2026)
Figure 55. North America Pharmaceutical CXO Revenue Market Share by Country (2016-2026)
Figure 56. United States Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Canada Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Mexico Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Europe Pharmaceutical CXO Sales Market Share by Type (2016-2026)
Figure 60. Europe Pharmaceutical CXO Sales Market Share by Application (2016-2026)
Figure 61. Europe Pharmaceutical CXO Revenue Market Share by Country (2016-2026)
Figure 62. Germany Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. France Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. United Kingdom Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Russia Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Italy Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Asia-Pacific Pharmaceutical CXO Sales Market Share by Type (2016-2026)
Figure 68. Asia-Pacific Pharmaceutical CXO Sales Market Share by Application (2016-2026)
Figure 69. Asia-Pacific Pharmaceutical CXO Revenue Market Share by Region (2016-2026)
Figure 70. China Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Japan Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. South Korea Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. India Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Southeast Asia Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Australia Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South America Pharmaceutical CXO Sales Market Share by Type (2016-2026)
Figure 77. South America Pharmaceutical CXO Sales Market Share by Application (2016-2026)
Figure 78. South America Pharmaceutical CXO Revenue Market Share by Country (2016-2026)
Figure 79. Brazil Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Argentina Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Middle East and Africa Pharmaceutical CXO Sales Market Share by Type (2016-2026)
Figure 82. Middle East and Africa Pharmaceutical CXO Sales Market Share by Application (2016-2026)
Figure 83. Middle East and Africa Pharmaceutical CXO Revenue Market Share by Country (2016-2026)
Figure 84. Turkey Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Saudi Arabia Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. UAE Pharmaceutical CXO Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 87. Methodology
Figure 88. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
WuXi AppTec Tigermed Charles River Laboratories Pharmaron Inc Labcorp Drug Development Boehringer Ingelheim GenScript MabPlex International Shanghai ChemPartner Wuxi Biologics Pharmablock Jiuzhou Pharma Asym Chemical IQVIA Syneos Health Parexel AGC Biologics FUJIFILM Diosynth Biotechnologies Patheon Catalent Lonza Group AG Avid Bioservices AbbVie
Related Reports
18 Jan 2022
Service & Software
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
